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Introduction: Behçet’s disease (BD) is a rare vasculitis in sub-Saharan Africa. Vascular thrombosis, especially venous,
is common in this condition and also constitutes a basic diagnostic criterion. Its affection of the superior vena cava
is rather rare with only a few cases described in the literature.
Case report: A 42-year-old male patient was seen at consultation presenting with a pulsatile, warm and slightly
painful right latero-cervical swelling extending to the supraclavicular fossa with the presence of collateral venous
circulation for three weeks prior to presentation associated with a mild headache. There were oral and genital
ulcerations and erythematous skin lesions associated with a history of inflammatory recurrent arthralgia. Chest
computed tomo-angiography showed cruoric internal jugular vein thrombosis extending to the superior vena cava
with significant venous collateral circulation. The patient was treated with prednisolone (1 mg/kg/day) and
colchicine (2 mg/day), as well as anticoagulation with heparin and vitamin K antagonist (Acenocoumarol) with
regular INR monitoring. Clinical evolution was favorable during hospitalization, with residual discrete right
supraclavicular swelling. There was no bleeding associated with anticoagulants use.
Conclusion: The case stresses the importance of maintaining a high degree of suspicion for Behçet’s disease in all
cases of venous thrombosis.
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Behçet’s disease (BD) is a multisystemic inflammatory
disease characterized by recurrent oral ulcers, genital ul-
cers, and uveitis. It is a rare vasculitis in sub-Saharan
Africa and is more common in the Mediterranean re-
gion. Vascular thrombosis, especially venous, is common
in this condition and also constitutes a basic diagnostic
criterion [1]. Its affection of the superior vena cava is ra-
ther rare with only a few cases described in the litera-
ture [2,3]. We present the case of a patient with Behçet’s
disease which was discovered during a superior vena
cava syndrome.Case report
A 42-year-old male patient was seen at consultation with
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unless otherwise stated.presentation associated with a mild headache. This pain,
described as heaviness, was sometimes located in the
mid-thoracic region, exacerbated by a slight dry cough
and associated with a low-grade fever and sometimes
with an exertional dyspnea. There was no associated
hemoptysis, vomiting, chills, sweating or dizziness. His
past medical history was unremarkable apart from re-
currence of oral and genital ulcers as well as inflamma-
tory arthralgia.
On admission, clinical examination revealed a hyper-
thermia at 38.3°C but was hemodynamically stable. There
was a warm, slightly painful, right latero-cervical swelling
extending to the supraclavicular fossa. There was evident
collateral venous circulation (Figure 1). The lung fields
were clear, and there were no palpable lymph nodes and
no signs of phlebitis. Further examination revealed healing
scrotal ulcers and oral ulcerations as well as erythematous
skin lesions.
Ophthalmologic examination was unremarkable. Labora-
tory tests showed a microcytic anemia with a hemoglobinis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Edema and significant collateral venous circulation (left), scrotal ulcer in recovery phase (right).
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cell count of 9,100/mm3. Admission electrocardiogram
noted a regular sinus tachycardia. Doppler transtho-
racic echocardiography noted a slight circumferential
pericardial effusion with no sign of pulmonary hyper-
tension or intracavitary thrombus.Figure 2 Thoracic CT angiography showing an internal jugular and suChest computed tomo-angiography showed cruoric
internal jugular vein thrombosis extending to the superior
vena cava with significant venous collateral circulation.
There was no hilar or mediastinal lymphadenopathy, nei-
ther was there any lung parenchymal abnormality (Figure 2).
The abdominopelvic ultrasound was normal.perior vena thrombosis.
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and colchicine (2 mg per day), as well as anticoagulation
with heparin and a vitamin K antagonist (Acenocoumarol),
with regular INR monitoring. Clinical evolution was favor-
able during hospitalization, with residual discrete right
supraclavicular swelling. There was no accident associated
with anticoagulants.
Discussion
BD is a systemic, inflammatory, immune dysfunction,
which is chronic and relapsing. It is characterized clinic-
ally by recurrent oral and genital ulcers, suggestive skin le-
sions (pseudo-folliculitis, reaction at injection sites etc.),
arthritis, uveitis and retinal vasculitis, central neurological
impairment, venous thrombosis and intestinal lesions.
There is no pathognomonic feature of BD and the diagno-
sis is based on clinical criteria such as those proposed by
the International Study Group for Behçet’s Disease, and
more recently, the International Team for the Revision of
the International Criteria for Behçet’s Disease [4,5]. The
diagnosis in our patient was clinical, and was based on re-
current genital and oral ulcerations and the presence ery-
thematous skin lesions using the criteria drawn up by the
International Study Group for Behçet’s Disease.
The disease is more prevalent in the Mediterranean re-
gion, the Middle East and in Japan [6]. It is rare in sub-
Saharan Africa with no data available on its actual preva-
lence [7]. However, reports from the continent suggest
that lack of awareness of the disease suggest that it is
possibly under-diagnosed [8].
The vascular manifestations are seen in 10-40% of cases
of BD [4] and it is predominantly venous which represents
80 to 90% of cases [9]. Vascular thrombosis are common
found in 19.7% in the Spanish registry according to
Rodriguez- Carballeira et al. who also found that men had
higher prevalence of ocular involvement and venous
thrombosis (52.5% vs. 39.2%, p = 0.004 and 26.3% vs. 9.6%,
p < 0.001, respectively) [10]. Ideguchi also found a male pre-
dominance of vascular manifestations in BD (62%), with
venous more than arterial (81% vs 31%) [11].
The common anatomical substratum of all these affec-
tions is vasculitis predominantly venous. The pathophysi-
ology of BD remains largely obscure. It is well established
that it involves infectious factors and abnormal immune
reaction, both innate and adaptive raising questions about
the nature of the BD: auto-inflammatory or autoimmune
or rather at the crossroads of the two [9].
Their thoracic vascular location is well known. Throm-
bosis of the superior vena cava is possible in Behçet’s dis-
ease and represents 2.5% of cases [6]. However, it is rarely
the presenting feature [12].
Superior vena cava thrombosis may be primary or sec-
ondary to an extension of axillary or subclavian vein throm-
bosis. It usually occurs a few years after the mucocutaneoussigns of the disease. Rarely, it is the inaugural manifestation
preceding the other events. Clinically, it may be latent, well
tolerated, with a silent evolution, or it may have a rather ag-
gressive manifestation characterized by chest pain, head-
ache, bilateral papilledema and fever. It is possible to have,
associated with the clinical features serous effusion as is the
case in our patient with a pericardial effusion. Its very na-
ture is sometimes chylous.
Patients with Behçet’s disease respond well to standard
steroid and colchicine treatment [13] and there was a
good evolution with our patient. Anticoagulation was
given to treat vascular thrombosis.
Imaging plays a fundamental role in the diagnosis.
This includes chest radiograph but especially computed
tomography and magnetic resonance imaging [6].
Conclusion
Although infrequent in our regions, Behçet’s disease
should be included in the search for etiological venous
thrombosis. Moreover, the orientating signs are quite
specific guidance.
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